Publication | Open Access
Epigenetic inactivation and tumor suppressor activity of <i>HAI‐2/SPINT2</i> in gastric cancer
48
Citations
35
References
2010
Year
Epigenetic ChangeEpigenetic InactivationPathologyCancer BiologyEpigeneticsTumor BiologyHgf ActivityCancer Cell BiologyCancer ResearchCancer GrowthMedicineTumor GrowthGastric CancerCancer GeneticsGene ExpressionEpigenetic RegulationCell BiologyChromatinNatural SciencesEpigenomicsCancer GenomicsTumor SuppressorSystems BiologyOncologyTumor Suppressor Activity
Hepatocyte growth factor (HGF) activator inhibitor type 2 (HAI-2/SPINT2) encodes Kunitz-type protease inhibitor that regulates HGF activity. Inspection of the human HAI-2/SPINT2 locus uncovered a large and dense CpG island within the 5' region of this gene. Analysis of cultured human gastric tumor lines indicated that HAI-2/SPINT2 expression is either undetectable or in low abundance in several lines; however, enhanced gene expression was measured in cells cultured on the DNA demethylating agent 5-aza-2'-deoxycytidine. Bisulfite DNA sequencing confirmed the densely methylated HAI-2/SPINT2 promoter region. Forced expression of HAI-2/SPINT2 induced cell apoptosis, suppressed anchorage independent growth in vitro and tumor growth in vivo. We investigated HAI-2/SPINT2 aberrant methylation in patients with gastric cancer. The HAI-2/SPINT2 methylation was found preferentially in cancerous tissues (30 of 40, 75%) compared with nontumor tissues (no methylation was detected), indicating that this aberrant characteristic is common in gastric malignancies. In conclusion, epigenetic inactivation of HAI-2/SPINT2 is a common event contributing to gastric carcinogenesis and may be a potential biomarker for gastric cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1